Announcing the winners Wednesday, April 11, 2018 Janet Dancy with Julie Wells accepting last year's award for the IND.214 team at Ottawa Hospital Research Institute Each year, at the CCTG Annual Spring Meeting of Participants, we recognize individuals and groups who have made significant contributions to cancer clinical trials research. Winners will be honoured on the evening of Friday, April 27 at the CCTG Recognition Awards Ceremony in Toronto. For full details, including bios and pictures, visit the Recognition Awards page. This year, the Recognition Award recipients are: Dr. Joseph Pater Founder's Award for Excellence in Clinical Trials Research This award recognizes an investigator whose leadership and body of work has contributed to significant advances in the understanding, diagnosis, treatment, cure, and prevention of cancer. Dr. J. Gregory Cairncross, University of Calgary Dr. Elizabeth Eisenhauer Early Drug Development Young Investigator Award This award is presented annually to an exceptional MD, fellow, or PhD, who has either spent time at CCTG's Operations and Statistics Centre, worked with the Investigational New Drug Program, or contributed significantly to an IND trial. Dr. John Hilton, Ottawa Hospital Research Institute Dr. Ralph Meyer Phase III Program Young Investigator Award This award is presented annually to any MD, fellow or PhD, who has either spent time at CCTG's Operations and Statistics Centre, worked on Phase III projects with Disease Site Committees, Endpoint Committees, or Working Groups, or who has contributed significantly to the conduct of a Phase III trial. Dr. Alysa Fairchild, University of Alberta Dr. Winson Cheung, University of Calgary Investigational New Drug Program Team Award This award is presented annually to a non-MD team of clinical research associates, nurses, pharmacists and others who participated in any Canadian Cancer Trials Group IND clinical trial to acknowledge their efforts and dedication to the success of clinical trials. IND.227 Team, Cross Cancer Institute, Edmonton IND.227 Team, NCI Naples Clinical Trials Unit, Italy Phase III Program Team Award This award is presented annually to individual trial teams from Canadian member centres to acknowledge their efforts and dedication to the success of clinical trials. PA.7 Team, BCCA - Vancouver Cancer Centre MEC.5 Team, Juravinski Cancer Centre at Hamilton Health Sciences
